Back to Search Start Over

Desmopressin/indomethacin combination efficacy and safety in renal colic pain management: A randomized placebo controlled trial.

Authors :
Jalili M
Shirani F
Entezari P
Hedayatshodeh M
Baigi V
Mirfazaelian H
Source :
The American journal of emergency medicine [Am J Emerg Med] 2019 Jun; Vol. 37 (6), pp. 1009-1012. Date of Electronic Publication: 2018 Aug 11.
Publication Year :
2019

Abstract

Introduction: Renal colic is a prevalent cause of abdominal pain in the emergency department. Although non-steroidal anti-inflammatory drugs and opioids are used for the treatment of renal colic, some adverse effects have been reported. Therefore, desmopressin -a synthetic analogue of vasopressin- has been proposed as another treatment choice. In the present study, indomethacin in combination with nasal desmopressin was compared with indomethacin alone in the management of renal colic.<br />Methods: Included in the study were 124 patients with initial diagnosis of renal colic and randomized to receive indomethacin suppository (100 mg) with either desmopressin intranasal spray (4 puffs, total dose of 40 micrograms) and or placebo intranasal spray.<br />Results: All the included patients were finally diagnosed with renal colic. There was no difference between the two groups in pain at the baseline (p = 0.4) and both treatments reduced pain successfully (p < 0.001). There was no significant difference between the two groups in pain reduction (p = 0.35).<br />Conclusions: While there was significant pain reduction in both patients groups, pain reduction of NSAIDs (e.g. indomethacin) in renal colic, does not significantly improve when given in combination with desmopressin.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1532-8171
Volume :
37
Issue :
6
Database :
MEDLINE
Journal :
The American journal of emergency medicine
Publication Type :
Academic Journal
Accession number :
30126672
Full Text :
https://doi.org/10.1016/j.ajem.2018.08.033